Status:
UNKNOWN
Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With Erlotinib
Lead Sponsor:
Aarhus University Hospital
Collaborating Sponsors:
University of Aarhus
The Ministry of Science, Technology and Innovation, Denmark
Conditions:
Non-Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Recently it has been suggested that specific mutations in the EGFR gene in lung cancer patients is associated with response to a novel drug targeting the EGF system. Recent research also indicates tha...
Detailed Description
Aim: 1. To establish a method for identifying the mutations in the EGFR gene in small clinical samples from lung cancer patients. 2. In a retrospective study(n=500) relate survival to the frequency a...
Eligibility Criteria
Inclusion
- Patients who are starting treatment with erlotinib and who has who has signed the informed consent.
Exclusion
- None
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2011
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00815971
Start Date
May 1 2008
End Date
May 1 2011
Last Update
December 31 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
department of oncology, University Hospital of Aarhus, Nørrebrogade 44
8000 Aarhus, Denmark